| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -7.4e-05 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 6.4e-05 | 1 |